Supernus Pharmaceuticals
SUPN
SUPN
289 hedge funds and large institutions have $1.81B invested in Supernus Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 119 increasing their positions, 78 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
289
Holders Change
+15
Holders Change %
+5.47%
% of All Funds
6.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
42
Increased
119
Reduced
78
Closed
25
Calls
$8.25M
Puts
$15.1M
Net Calls
-$6.8M
Net Calls Change
-$3.15M
Top Buyers
| 1 |
NPIC
Neumeier Poma Investment Counsel
Carmel,
California
|
+$15.9M |
| 2 |
Two Sigma Investments
New York
|
+$12.2M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$11.4M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$8.66M |
| 5 |
Two Sigma Advisers
New York
|
+$8.14M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$47.1M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$8.43M |
| 3 |
Bank of New York Mellon
New York
|
-$5.82M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$5.61M |
| 5 |
Morgan Stanley
New York
|
-$5.26M |
